Skip to main content

Clifford Chance
News and awards

News and awards

Clifford Chance advises Gushengtang on US$110 million convertible bond issuance to an investment vehicle of Boyu Capital

16 February 2026

Clifford Chance advises Gushengtang on US$110 million convertible bond issuance to an investment vehicle of Boyu Capital

Global law firm Clifford Chance has advised Gushengtang Holdings Limited on its US$110 million convertible bond issuance to an investment vehicle of Boyu Capital. The Company appointed CICC as its financial adviser in relation to the issuance. Gushengtang is a leading provider of traditional Chinese medical and health services across Mainland China and Singapore.

Gushengtang expects the above strategic investment to create synergies, which assists it to strengthen its leading position in the Greater China region and Singapore and brings unparalleled experiences and expertise in expanding its presence in Mainland China, Singapore, and other overseas markets in order to achieve profitable long term growth.

Lead partner David Tsai said, "We are pleased to have advised Gushengtang on this significant transaction, which reflects the continued role of private capital as a key driver in the resurgence of convertible bond financings in Hong Kong where investors and issuers are seeking bespoke and execution‑efficient solutions."

David led the deal and was supported by senior associates Kenneth Ip and Michael Cheng.

高伟绅就固生堂向博裕资本旗下投资载体发行1.1亿美元可转换债券提供法律服务

高伟绅就固生堂控股有限公司向博裕资本旗下投资载体发行1.1亿美元可转换债券提供法律服务。本次发行由固生堂委任中金公司担任财务顾问。固生堂是中国内地及新加坡领先的中医医疗和健康服务的投资控股公司。

高伟绅就固生堂控股有限公司向博裕资本旗下投资载体发行1.1亿美元可转换债券提供法律服务。本次发行由固生堂委任中金公司担任财务顾问。固生堂是中国内地及新加坡领先的中医医疗和健康服务的投资控股公司。

固生堂预计,上述战略投资将产生协同效应,助力其巩固在大中华地区及新加坡的领先地位,并凭借无与伦比的经验与专长,进一步拓展中国内地、新加坡及其他海外市场,以实现可盈利的长期增长。

牵头合伙人蔡重阳表示:"我们很高兴能协助固生堂完成这一重大交易。本次交易彰显了私募资本持续发挥关键作用,推动香港可转债融资市场复苏 — 当前投资者与发行人正寻求定制化且执行高效的融资解决方案。"

合伙人蔡重阳牵头负责本次交易,项目团队成员包括叶家进(Kenneth Ip)和成林(Michael Cheng)。